Abstract

The changes in gustatory function resulting from oncological treatment occur mainly after radiotherapy. However, the head and neck tumors, because of the anatomical location of the lesion, can themselves trigger significant changes in the feeding-related functions - including taste. To assess the gustatory function in patients diagnosed with advanced oral cavity and oropharyngeal cancer. This descriptive cross-sectional study comprised 31 individuals with advanced oral cavity and oropharyngeal cancer, referred for oncological treatment with radiotherapy, either alone or in combination with chemotherapy. The "taste strips" test was applied; it consists of inserting solutions with four different concentrations each for salty, sweet, and sour tastes, and three concentrations for the bitter taste, on the tongue. Most of the individuals were diagnosed with oropharyngeal cancer. Approximately half of the sample already had taste-related complaints, and more than 80%, swallowing-related complaints. The overall frequency of hypogeusia was 38.7%, in which the bitter taste stood out in its isolated assessment. The association of change in gustatory function proved to be significant in patients in stage T4. The decrease in gustatory function in individuals with oral cavity and oropharyngeal cancer was evidenced in this study, especially when associated with tumors in stage T4. Regarding feeding, most of them reported complaints of dysphagia, suggesting the importance of the speech-language-hearing assessment and follow-up, even before the oncological treatment, to minimize the risks of dysphagia.

Highlights

  • Mouth cancer is one of the most frequent types of head and neck tumors, and the fifth among the types of cancer with the highest incidence in men (5.2%)(1)

  • This study aimed to assess the gustatory function in patients diagnosed with advanced oral cavity and oropharyngeal cancer, describing complaints related to taste and swallowing, assessing the identification of sweet, salty, sour, and bitter tastes, and classifying the gustatory function in this profile of patients as ageusia, hypogeusia, and normogeusia, before radiotherapy treatment, besides relating the changes in the gustatory function with factors such as sex, age group, staging, and risk factors

  • This paper verified that approximately 42% of the individuals assessed already had taste-related complaints even before the radiotherapy treatment

Read more

Summary

Introduction

Mouth cancer is one of the most frequent types of head and neck tumors, and the fifth among the types of cancer with the highest incidence in men (5.2%)(1). The American Cancer Society[3] estimates that approximately 51,540 new cases of oral cavity and oropharyngeal cancer were diagnosed in the United States in 2018, with a survival rate of approximately five years. In Brazil, the estimates were of 11,200 new cases of oral cavity and oropharyngeal cancer in men, and 3,500 in women, a year in the 2018-2019 biennium[1]. These numbers correspond to an estimated risk of 10.86 new cases for every 100 thousand men and 3.28 for every 100 thousand women and the estimate of 5,401 deaths in 2013 – 4,223 men and 1.178 women[1]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call